Efficacy of anti-PD-1 antibody nivolumab in Japanese patients with metastatic renal cell carcinoma: A retrospective multicenter analysis

To evaluate the efficacy and safety of anti-PD1 therapy (nivolumab) in advanced renal cell carcinoma (RCC) in a clinical setting. Between March 2013 and January 2018, 33 patients with RCC (27 men and 6 women) were treated with nivolumab. Before anti-PD1 treatment, 12, 9 and 12 patients received one,...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Mol Clin Oncol
Main Authors: Numakura, Kazuyuki, Horikawa, Yohei, Kamada, Sachiko, Koizumi, Atsushi, Nara, Taketoshi, Chiba, Syuji, Kanda, Sohei, Saito, Mitsuru, Narita, Shintaro, Inoue, Takamitsu, Shimoda, Naotake, Habuchi, Tomonori
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2019
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6636209/
https://ncbi.nlm.nih.gov/pubmed/31341623
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2019.1887
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki